Nuvectis Pharma, Inc. (NVCT)

Import this data to Google Sheets with:

=jivedata("NVCT","financials")

Full statements spill as a table. For one cell: =jivedata("NVCT","Revenue") or =jivedata("NVCT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Nuvectis Pharma, Inc.

NVCT • CIK 0001875558

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Research and Development Expense	$15,380	$12,918	$18,153	$19,650
General and Administrative Expense	$7,517	$6,929	$9,421	$9,218
Operating Income (Loss)	$-22,897	$-19,847	$-27,574	$-28,868
Net Income (Loss) Attributable to Parent	$-22,260	$-19,000	$-26,442	$-27,846
Net Income (Loss) Available to Common Stockholders, Basic	$-22,260	$-19,000	$-28,871	$-30,275
Weighted Average Number of Shares Outstanding, Basic	15,556,655	17,113,169	21,812,716	24,602,257

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$19,126	$18,533	$31,634	$22,160
Other Assets, Current	$59	$74	$75	$216
Assets, Current	$19,185	$18,607	$31,709	$22,376
Liabilities	$6,984	$8,894	$13,296	$13,294
Accounts Payable, Current	$2,771	$2,498	$6,274	$5,184
Accrued Liabilities, Current	$415	$840	$115	$92
Employee-related Liabilities, Current	$3,798	$5,556	$6,907	$6,630
Additional Paid in Capital	$66,446	$82,958	$118,100	$121,839
Retained Earnings (Accumulated Deficit)	$-54,245	$-73,245	$-99,687	$-112,757
Stockholders' Equity Attributable to Parent	$12,201	$9,713	$18,413	$9,082
Common Stock, Shares Authorized	60,000,000	60,000,000	60,000,000	60,000,000
Common Stock, Shares, Issued	17,418,886	19,495,683	25,676,798	26,694,828

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	$-867	$-593	$13,101	$-4,633
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$19,126	$18,533	$31,634	$26,900
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-22,260	$-19,000	$-26,442	$-27,846
Net Cash Provided by (Used in) Investing Activities	$0	$0	—	—
Proceeds from Issuance of Common Stock	$5,289	$12,036	—	$12,036
Payments of Stock Issuance Costs	$174	$382	—	$382
Net Cash Provided by (Used in) Financing Activities	$15,087	$11,654	$29,110	$14,877
Share-based Payment Arrangement, Noncash Expense	$4,705	$4,858	$6,032	$6,492
Increase (Decrease) in Other Current Assets	$-353	$15	$1	$2
Increase (Decrease) in Accounts Payable	$-139	$-273	$3,776	$207
Increase (Decrease) in Accrued Liabilities	$-30	$425	$-725	$90
Net Cash Provided by (Used in) Operating Activities	$-15,954	$-12,247	$-16,009	$-19,510

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("NVCT","financials")

Full statements spill as a table. For one cell: =jivedata("NVCT","Revenue") or =jivedata("NVCT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.